Has Paul Lowe received payments from drug or device companies?

Yes. Drug and device makers reported $7,449 in general payments to Paul Lowe across 308 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Lowe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Lowe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Lowe

Physician Assistant · Oklahoma City, OKNPI 1659697779

Payments from drug & device makers

$7,449in general payments, 2019–2025

Across 308 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$3K
AbbVie$990
Otsuka America Pharmaceutical, Inc.$675
Supernus Pharmaceuticals, Inc.$398
Axsome Therapeutics, Inc.$375
Teva Pharmaceuticals USA, Inc.$355
plus $2K from 18 others

What the payments were for

Food & beverage$7,21197%
Education$2383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	80	$2,725
AbbVie	86	$990
Otsuka America Pharmaceutical, Inc.	33	$675
Supernus Pharmaceuticals, Inc.	13	$398
Axsome Therapeutics, Inc.	5	$375
Teva Pharmaceuticals USA, Inc.	9	$355
Neurocrine Biosciences, Inc.	9	$303
Alkermes, Inc.	15	$297
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$287
Janssen Scientific Affairs, LLC	2	$174
E.r. Squibb & Sons, L.L.C.	5	$173
Vanda Pharmaceuticals Inc.	7	$137
Lundbeck LLC	7	$122
Noven Pharmaceuticals, Inc.	1	$108
Sunovion Pharmaceuticals Inc.	6	$77
Bausch Health US, LLC	3	$66
Indivior Inc.	4	$54
Noven Therapeutics, LLC	2	$29
Avanir Pharmaceuticals, Inc.	2	$28
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$23
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Biodelivery Sciences International, Inc.	1	$15
Ironshore Pharmaceuticals Inc.	1	$14
Sage Therapeutics, LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,449 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma →

Other physician assistant in Oklahoma City

Jennifer SmithOklahoma City$134K
Sarah HawkOklahoma City$23K
Brooke CromerOklahoma City$14K
Mary Jane RorickOklahoma City$14K
Alma HintzeOklahoma City$14K
Emily McLainOklahoma City$13K
Deniz AktasOklahoma City$13K
Jovonne SmithOklahoma City$12K
Anthony SharpOklahoma City$11K
Whitney PriceOklahoma City$11K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →